(Q44045391)

29 November 2017

title

Clinical significance of CDH13 promoter methylation in serum samples from patients with bladder transitional cell carcinoma (English)

1 reference

29 November 2017

Y L Lin

1

1 reference

29 November 2017

G Sun

2

1 reference

29 November 2017

X Q Liu

3

1 reference

29 November 2017

W P Li

4

1 reference

29 November 2017

J G Ma

5

1 reference

29 November 2017

publication date

1 January 2011

1 reference

Journal of International Medical Research

29 November 2017

published in

1 reference

29 November 2017

volume

39

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

179-186

1 reference

Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

The present and future burden of urinary bladder cancer in the world

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

Bladder cancer in 2010: how far have we come?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

Loss of prostasin (PRSS8) in human bladder transitional cell carcinoma cell lines is associated with epithelial-mesenchymal transition (EMT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

Bladder cancer angiogenesis and metastasis--translation from murine model to clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

Defining optimal therapy for muscle invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

H-cadherin expression reduces invasion of malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

H-cadherin expression inhibits in vitro invasiveness and tumor formation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

DNA methylation and cancer diagnosis: new methods and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

Epigenetic markers as promising prognosticators for bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

Epigenetics in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

Guidelines on bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

Aberrant methylation of H-cadherin (CDH13) promoter is associated with tumor progression in primary nonsmall cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

Epigenetic biomarkers in urothelial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

Genetic polymorphisms of MTHFR and aberrant promoter hypermethylation of the RASSF1A gene in bladder cancer risk in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

Methylation in p14(ARF) is frequently observed in colorectal cancer with low-level microsatellite instability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

DNA methylation based biomarkers in non-invasive cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

Bladder cancer: clinical and pathological profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

DNA methylation markers and early recurrence in stage I lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

Molecular biomarkers for urothelial carcinoma of the bladder: challenges in clinical use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

Molecular markers for detection, surveillance and prognostication of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

Circulating DNA: a new diagnostic gold mine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

Circulating nucleic acids in plasma or serum (CNAPS) as prognostic and predictive markers in patients with solid neoplasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

DNA methylation as a universal biomarker

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F147323001103900119

10.1177/147323001103900119

21 January 2018

Identifiers

DOI

1 reference

29 November 2017

1 reference